DiaMedica Therapeutics, Inc.
DiaMedica-Logo
Navigate DiaMedica Therapeutics, Inc.
Home
About Us
Overview
Leadership Team
Board of Directors
Advisors
Pipeline
Pipeline
Lead Product
Chronic Kidney Disease
Acute Ischemic Stroke
Clinical Trials
News
Investors
Investor Overview
Events and Presentations
Nasdaq Stock Information
Analyst Coverage
Financials & Filings
Corporate Governance
FAQ
Email Alerts
Careers
Contact
Home
News
News
All News
By Year:
2019
2018
2017
2016
Dec 23, 2016
DiaMedica Announces Name Change to DiaMedica Therapeutics Inc.
Dec 20, 2016
DiaMedica Announces Positive Top-Line Results from DM199 Bridging Clinical Trial
Dec 7, 2016
DiaMedica Expands its Business Development Capabilities
Dec 1, 2016
DiaMedica Announces the Sale and Transfer of its DM-71 Product for Type 2 Diabetes
Nov 28, 2016
DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders
Oct 12, 2016
DiaMedica Establishes Neurological Scientific Advisory Board With Several Distinguished Experts
Oct 5, 2016
DiaMedica Announces First Patient Enrolled in Bridging Clinical Trial for DM199
Sep 26, 2016
DiaMedica to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference
Sep 12, 2016
DiaMedica Announces Regulatory Clearance to Initiate Bridging Clinical Trial for DM199
Sep 8, 2016
DiaMedica Completes Second Tranche of Non-Brokered Private Placement With Hermed Capital
1
2
Next »